2024-09-03 - Analysis Report
## Stock Analysis Report: ABT (Abbott Laboratories)

**Company Overview:** Abbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and sells a wide range of medical devices, pharmaceuticals, and nutrition products. 

**Performance Analysis:**

1. **Performance vs. S&P 500 (VOO):** 
    * ABT's cumulative return is 41.96%, significantly lagging behind the S&P 500 (VOO) which has returned 89.66%.
    * The relative underperformance of ABT is -47.7% compared to VOO, which places it at the 14.85 percentile of historical performance data. This means ABT has underperformed the market for most of its historical data period.

2. **Recent Price Movements:** 
    * ABT closed at $113.27, with a 5-day moving average of $112.95, a 20-day moving average of $110.9, and a 60-day moving average of $106.71.
    * The short-term price action suggests a slight upward trend, with the price above all moving averages.

3. **Technical Indicators:**
    * **RSI:** The RSI of 82.52 indicates that ABT is currently in overbought territory, suggesting potential for a near-term correction. 
    * **PPO:** The PPO of 0.03 suggests a bullish trend, although relatively weak. 
    * **Relative Divergence:** The recent (20-day) relative divergence of -8.38 indicates a potential for a short-term downturn.
    * **Expected Return:** The expected return of 27.09% is based on a 5-year horizon and is highly speculative.

4. **Recent Earnings and Outlook:**
    * ABT's recent earnings have been relatively stable, with EPS ranging from $0.7 to $0.82. However, the most recent earnings (2024-07-31) of $0.74 missed analyst estimates, suggesting a potential for slower growth.
    * The company's revenue growth has also been relatively stable, although slightly declining in the most recent quarter.

**Overall Analysis:**

ABT's performance has significantly lagged behind the S&P 500, and recent price action suggests potential for a correction. Although technical indicators point to a bullish trend, the recent earnings miss and high RSI suggest a potential short-term downturn. The expected return is high but speculative, requiring further analysis. Further research and consideration of the company's long-term prospects are recommended before making any investment decisions. 
